Single Blinded First CMC Osteoarthritis Treatment
Not Applicable
Recruiting
- Conditions
- Osteoarthritis Thumb
- Interventions
- Drug: Platelet ConcentrateDrug: Corticosteroid injectionOther: Normal Saline
- Registration Number
- NCT03196310
- Lead Sponsor
- Kettering Health Network
- Brief Summary
Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Stage 1-3 osteoarthritis of the basal joint
Exclusion Criteria
- Patients with Stage 4 1st carpometacarpal joint arthritis as described by Eaton
- Patients who have received a corticosteroid injection in the last year to the 1st CMC joint on the proposed study side
- Patients who have scaphotriquetral, radioscaphoid, or scaphotrapezial osteoarthritis
- Patients who have concurrent DeQuervain's tenosynovitis or intersection syndrome or have been treated for either of these in the last 3 months
- Patients undergoing evaluation of cervical radiculopathy
- Patients with fibromyalgia or inflammatory rheumatic disease
- Patients with Pressier disease, Kienbock's, or avascular necrosis of the scaphoid
- Patients with any history of primary or secondary bone tumor
- Patients that are pregnant or terminally ill
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description PRP Platelet Concentrate Intra-articular injection of platelet rich plasma. Corticosteroid Corticosteroid injection Intra-articular injection of kenalog. Normal Saline Normal Saline Intra-articular injection of normal saline
- Primary Outcome Measures
Name Time Method Disabilities arm shoulder and hand score 1 year functional score
- Secondary Outcome Measures
Name Time Method Pinch Strength 1 year Objective measurement
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie PRP efficacy in thumb osteoarthritis compared to corticosteroids?
How does leukocyte-depleted PRP compare to corticosteroid injections for first CMC osteoarthritis outcomes?
Which biomarkers predict response to intra-articular corticosteroids vs. PRP in basal joint arthritis?
What are the long-term adverse event profiles of PRP and corticosteroid treatments for thumb OA?
Are combination therapies of PRP with bracing more effective than monotherapies for first CMC OA?
Trial Locations
- Locations (1)
Orthopedic Associates of Southwest Ohio
🇺🇸Centerville, Ohio, United States
Orthopedic Associates of Southwest Ohio🇺🇸Centerville, Ohio, United StatesLaura PetersonContact800-824-9861lpeterson@oaswo.com